- Ko, L. and Pieves, C. (1996) "p53: Puzzle and paradigm", Genes and Development 10, 1054-1072.
- Levine, A. (1997) " P53, The cellular gatekepper for growth and division", Cell 88, 323-331.
- Ford, J.M. and Hanawalt, P.C. (1997) "Role of DNA excision repair gene defects in the ethiology of cancer", Current Topics Microniology and Immunology 221, 47-70.
- Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., H., Nagai, H., Tsushita, K., Saito, H. and Hotta, T. (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma". New England Journal of Medicine 337, 529- 534.
- Koduru, P.R., Raju, K., Vadmal, V., Menezes, G., Shah, S., Susin, M., Kolitz, J. and Broome, J.D. (1997) "Correlation between mutation in p53, p53 expression, cylogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma", Blood 90, 4078-4091.
- Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, k A., Newcomb, E., Macgrath, IT., Knowles, D.M. and Dalla-Favera, R. (1991) "p53 mutations in human lymphold malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia", Proceedings of the National Academy of Science USA 88, 5413-5417.
- Lindstrom, M.S., Klangby, and Wiman, K.G. (2001) "p14ARF homozygous deletion or MDM2 overexpresssion in Burkitt lymphoma lines carrying wildtype p53", Oncogene 20, 2171-2177.
- Barrans, S.L., Carter, I., Owen, R.G., Davies, F.E., Patmore, R.D., Haynes, A.P., Morgan, G.J. and Jack, A.S, (2002) "Germinal center phenotype and Bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell 1ymphoma", Blood 99, 1136-1143.
- Tavor, S., Takeuchi, S., Tsukasaki, K., Miller, C.W., Said, J.W. and Koeffler, H.P (2001) "Analysis of the CHK2 gene in lymphoid malignancies", Leukemia and Lymphoma 42, 517-520.
- Camacho, E., Hernandez, L., Hernandez, S., Tort, F., Bellosillo, B., Bea, S., Bosch, F., Montserrat, E., Cardesa, A., Fernandez, P.L. and Campo, E. (2002) "ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidytinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances", Blood 99, 238-244.
- Stankovic, T., Stewart, G.S., Fegan, C., Biggs, P., Last. J., Byrd, P.J., Keenan, R.D., Moss, P.A. and Taylor, A.M. (2002) "Ataxia telangiectasia, mutated deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage". Blood 99, 300-309.
- Kawaski, C., Ohshim, K., Suzumiya, J., Kanda, M., Tsuchiya, T., Tamura, K. and Kikuchi, M. (2001) "Rearrangements of Bcl-1, Bcl-2, Bcl-6, and c-Myc in diffuse B-cell lymphoma", Leukemia and Lymphoma, 42, 1099-1106.
- Lossos, I., Jones, C.D., Warnke, R., Natkunam, Y., Kaizer, H., Zehnder, J.L., Tibshirani, R. and Levy, R. (2001) "Expression of a single gene. Bcl-6, Strongly predients survival in patients with diffuse large B-cell lymphoma", Blood 98, 945-951.
- Adida, C, Haioun, C., Gaulard, P., Lepage, E., Morel, P., Briere, L., Dombert, H., Reyes, F., Diebold, J., Gisselbrechat, C., Salles, G., Altieri, D.C., and Molina, T.J. (2000) "Prognostic significance of survival expression in diffuse large B-cell lymphoma". Blood 96, 1921-1921.
- Samuels-Lev, Y., O'Cunnor, D.J., Bergamaschi, D,. Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T. and Lu, X, (2001). "ASPP proteins specifically Stimulate the apoptotic function of p53", Molecular cell 8, 781-794.
- Lopez, C.D., Ao, Y., Rohde, L.H., Perez, T.D., O'Connor, D.J., Lu, X., Ford, J.M. and Naumovski, L. (2000) "Pro-apoptotic p53interacting protein 53BP2 is induced by UV irradiation but suppressed by P53", Molecular and Cellular Biology 20, 8018-8025.
- Iwabuchi, K., Li. B., Massa, H.F., Trask, B.J., Takayasu, D. and Field, S. (1998) "Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2", The Journal of Biological Chemistry 273, 26061-26068.
- Mori, T., Okamoto, H., Takahashi, N., Ueda, R. Okamoto, T. (2000) "Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines", FEBS Letters 465, 124-128.
- Sgroi, D.C., Teng, S., Robinson, G., LeVangie, R., Hudson, J.R., and Elkahloun, A.G. (1999) "In vivo expression expression profile analysis of humun breast cancer progression" Cancer Research 59, 5656-5661.
- Gendler, S.J., Cohen, E.P., Craston, A., Duhig, T., Johnstone, G. and Barnes, D. (1990) "The locus of the polymorphic epithelial mucin (PEM) tumour antigen chomosome 1q21 shows a high frequency of alteraliim in primary human breast tumours", International Journal of Cancer 45, 431-435.
- Li, Y.S., Ramsay, D.A., S., F.Y., Armstrong, R.F. and Del Maestro, R.F (1995) "Cytogenede evidence that a tumor suppressor gene in the long arm of chromosome 1 contributes to glioma growth", Cancer Genetics and Cytogenetics 84, 46-50.
- Muity, V.V., Li, R.G., Mathew, S., Reuter, V.E., L., B.D., Bosl, G.J. and Chaganti, R.S. (1994) "Replication error-type genetic instability at 1q42-43 in human male germ cell tumors", Cancer Research 54, 3981-3985.
- Haglund, U., Juliusson, G., Stellan, B. and Gahrton, G. (1994) "Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions", Blood 83, 2637-2645.
- Mertens, F., Mandahl, N., Orndal, C., Baldetorp, B., Bauer, H.C., Rydholm, A., Weibe, T., Willen, H., Akerman, M. and Heim, S. (1993) "Cutpgemetoc findings in 33 osteosarcomas", International Journal of Cancer 55, 44-50.
- Schlegelberger, B., Zwingers, T., Harder, L., Nowotny, H., Siebert, R., Vesely, M., Bartels, H., Sonnen, R., Hopfinger, G., Nader, A., Ott. G., Muller-Hermelink, K., Feller, A. and Heinz, R. (1999) "Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma", Blood 94, 3114-3120.
- Alizadeh, A, Eisen, M., Davis, R., Ma C., Lossos, I., Rossenwald, A., Boldrick, J., H., Tran, T., Yo, X., Powell, J., Yang, L., Marti, G., Moore, T., Hudson, J.R., Lu, L., Lewis, D., Tibshirani, R., Sherlock, G., Chan, W., Greiner, T., Weisenburger, D., Arimitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M., Byrd, J.C., Botstein, D., Brown, P. and Staudt, L.M. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling". Nature 403, 503-511.
- Cabanillas, F., Horning, S., Kaminski, M. and Champlin, R. (2000) "Managing indolent lymphomas in relapse: working our way through A plethora of options". Hematology (American Society of Hematology Educational Program), 166-179.
- Multani, P., White, C.A. and Griilo-Lopez, A. (2001) "NonHodgkin's lymphoma; a review of conventional treatments", Current Pharmacology and Biotechnology 2, 279-291.
- Rosenbeig, S.A. (1985) "Karnofsky memorial lecture. The lowgrade non-Hodgkin's lymphomas: challenges and opportunities", Journal of Clinical Oncology 3, 299-310.
- Shipp, M., Harris, N. and Mauch, P. (1997) "The non-Hodgkin's lymphomas". In: DeVita, V.T., Hellman, S. and Rosenberg, S.A., eds, Cancer Principles and Practices, of Oncology (Lippincott, Philadelphia), pp 2165-2220.
- Harris, N., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K,. Cleary, ML., Delsol, G., De Wolf-Peelers., C,. Falini, B. and Gatter, K.C. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group (see comments)". Blood, 1361-1392.
- (1997) "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphonw: the nonHodgkin's lymphoma classiticaiion project", Blood 89, 3909-3918.
- (1993) "A predictive model for aggressive non-Hodgkin's lymphoma: the international non-Hodgkin's lymphoma prognostic factors project". New England Journal of Medicine 329, 987-994.
- Ford, J.M. and Hanawalt, P.C. (1997) "Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated hitman fibroblasts", The Journal of Biological Chemistry 272, 28073-28080.
- Bindl, J.M. and Warnke, R.A. (1986) "Advantages of detecting monoclonal antihody binding to tissue sections with biotin and avidin reagents in coplin jars", American Journal of Clinical Pathology 85, 490-493.
- Ao, Y., Rohde, L.H. and Naumovski, L. (2001) "p53-Interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apotosis", Oncogene 20, 2720-2725.
- Kramer, M.H., Hermans, J., Parker, J., Krol, A.D., Kluin-Nelemans, J.C., Haak, H.L., van Groningen, K., van Krieken, J.H., de Jong, D. and Kluin, P.M. (1996) "Clinical significance of Bcl-2 and p53 protein expression in diffuse large B-cell lymphoma: a populationbased study", Journal of Clinical Oncology 14, 2131-2138.
- Naumovski, L. and Cleary, M.L. (1996) "The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M", Molecular and Cellular Biology 16,. 3884-3892.
- Yang, J., Hori, M., Takahashi, N., Kawabe, T., Kato, H. and Okamoto, T. (1999) "NF-kB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2". Oncogene 18, 5177-5186.
- Nakagawo, H., Koyama, K., Murata, Y., Murito, M., Akiyanw, T. and Nakamura, Y, (2000) "APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocales it to the perinucleus", Cancer Research 60, 101-105.
- Helps., N., Barker, H., Elledge, S.J. and Cohen, P. (1995) "Protein phosphamse 1 interacts with p53BP2. a protein which binds to the tumour suppressor p53". FEBS Letters 377, 295-300.
- Jenkins, R.B., Bartelt, D.J., Stalboerger, P., Persons, D., Dahl. R.J., Podralz, K., Keeney, G. and Hartmann, L. (1993) "Cytogenetic studies of epithelial ovarian carcinomas". Canter Genetics and Cytogenetics 71, 76-86.
- Hedenfalk, M.S., Duggan, D., Chen, Y., Radmucher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Kallioniemi, O., Willbnd, B., Borg, A. and Trent, J. (2001) "Gene-expression profiles in hereditary breast cancer". New England Journal of Medicine 344, 539-548.
- Pomeroy, S., Tamayu, P., Gaasenbeek, M, Sturia, L.M., Angelo, M. McLaughlin, M., Kim, J., Goumnerova, L., Black, P., Lau, C., Allen, J., Zagsag. D., Oison. J., Curran. T., Wetmore, C., Biegel, J., Poggio, T., Mukherjee. S., Riftin, R., Calitano, A., Stolovitsky, G., Louis, D., Mesirov, J., Lander, E. and Golub, T. (2002) "Prediction of central nervous system embryonal tumour outcome based on gene expression". Nature 415, 436-442.
Apoptosis Stimulating Protein of p53 (ASPP2) Expression Differs in Diffuse Large B-cell and Follicular Center Lymphoma: Correlation with Clinical Outcome
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.